Shane Barton - 18 Dec 2024 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Principal Accounting Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
18 Dec 2024
Net transactions value
$0
Form type
4
Filing time
20 Dec 2024, 16:04:55 UTC
Previous filing
10 Mar 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 18 Dec 2024 Common Stock 40,000 $4.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.